Your browser doesn't support javascript.
loading
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder.
Biotti, Damien; Lerebours, Fleur; Bonneville, Fabrice; Ciron, Jonathan; Clanet, Michel; Brassat, David.
  • Biotti D; Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France.
  • Lerebours F; Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France.
  • Bonneville F; Unité de neuroradiologie, Hôpital Pierre-Paul-Riquet, CHU Purpan, Toulouse, France.
  • Ciron J; Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France.
  • Clanet M; Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France; INSERM UMR 1043, Université Toulouse III, Toulouse, France.
  • Brassat D; Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France; INSERM UMR 1043, Université Toulouse III, Toulouse, France.
Mult Scler ; 24(12): 1645-1647, 2018 10.
Article en En | MEDLINE | ID: mdl-29741120
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos / Neutropenia Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos / Neutropenia Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article